Trial Details

COMPLETED
Basic Information
Clinical ID c1236
Identifier NCT00505778
Trial Title A Comparison of Once a Day Dose Compared to 2 Doses/Day
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: Mesalamine Once-Daily|DRUG: Mesalamine Twice-Daily
Participant Information
Sponsor Warner Chilcott
City Athens
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-07-07
Primary Completion Date 2025-07-09
Completion Date 2025-07-09